New Weight-Loss shot shows promise in early trial
Disease control
Completed
This early-stage trial tested an investigational injection called PB-119 in 32 Chinese adults with obesity. The main goal was to check safety and how the drug moves through the body, while also measuring weight loss. Participants received either the drug or a placebo, and the stu…
Phase: PHASE1, PHASE2 • Sponsor: PegBio Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:53 UTC